PERFILES GENÉTICOS (IS6110) Y PATRONES DE RESISTENCIA EN AISLAMIENTOS DE M. tuberculosis DE PACIENTES CON TUBERCULOSIS PULMONAR. LIMA SUR, PERÚ.

Objectives: To know the genetic profile of M. tuberculosis, and to determine its drug resistance pattern in a population consisting in infected subjects from southern Lima using the IS610 genetic marker (RFLP-IS6110). Materials and Methods: Between october 2002 and april 2003 patients older than 15...

Descripción completa

Detalles Bibliográficos
Publicado en:Revista Peruana de Medicina Experimental y Salud Pública Vol. 22; no. 1; pp. 4 - 12
Autores principales: Capcha A., Luis, Urbina B., Martha, Vásquez C., Lucy, Asencios S., Luis, Quispe T., Neyda, Leo H., Elena, Baldeviano V., Christian, Zavaleta P., Amparo
Formato: Artículo
Publicado: Instituto Nacional de Salud (Peru) 2005
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=24052164&site=ehost-live
header:
  @attributes:
    shortDbName: lth
    uiTerm: 24052164
    longDbName: MedicLatina
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        17264634
        2WT0
      jtl: Revista Peruana de Medicina Experimental y Salud Pública
      issn: 17264634
      maglogo: N
    pubinfo:
      dt: 2005
      vid: 22
      iid: 1
      pid: 27380
      pub: Instituto Nacional de Salud (Peru)
    artinfo:
      ui: 24052164
      ppf: 4
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
            size: 217KB
      tig:
        atl: PERFILES GENÉTICOS (IS6110) Y PATRONES DE RESISTENCIA EN AISLAMIENTOS DE M. tuberculosis DE PACIENTES CON TUBERCULOSIS PULMONAR. LIMA SUR, PERÚ.
      aug:
        au:
          Capcha A., Luis
          Urbina B., Martha
          Vásquez C., Lucy
          Asencios S., Luis
          Quispe T., Neyda
          Leo H., Elena
          Baldeviano V., Christian
          Zavaleta P., Amparo
        affil:
          Laboratorio del Hospital María Auxiliadora, Lima, Perú
          Laboratorio de Referencia Nacional de Mycobacterias, Instituto Nacional de Salud, Lima, Perú,
          Laboratorio de Biología Molecular, Instituto Nacional de Salud, Lima, Perú
          Departamento de Biología Molecular, Facultad de Farmacia y Bioquímica, Universidad Nacional Mayor de San Marcos, Lima, Perú
      su:
        Tuberculosis
        Drug resistance
        Genetic markers
        Tuberculosis patients
        Health facilities
        Lima (Peru)
        Peru
      sug:
        subj:
          Lima (Peru)
          Peru
          Tuberculosis
          Drug resistance
          Genetic markers
          Tuberculosis patients
          Health facilities
      keyword:
        Drug resístanse
        Genetic code
        M. tuberculosis/genotipification
        Molecular Epidemiology
        Polymorphism
        restriction fragment length
        Códigos genéticos
        Epidemiología Molecular
        M. tuberculosis / genotipificación
        Perú
        Polimorfismo de longitud del fragmento de restricción
        Resistencia a drogas
        Tuberculosis
      ab:
        Objectives: To know the genetic profile of M. tuberculosis, and to determine its drug resistance pattern in a population consisting in infected subjects from southern Lima using the IS610 genetic marker (RFLP-IS6110). Materials and Methods: Between october 2002 and april 2003 patients older than 15 years of age diagnosed with pulmonary tuberculosis (TB) by a positive sputum smear were included. Patients were recruited from health facilities in Villa Maria del Triunfo district and Maria Auxiliadora Hospital. Susceptibility testing for all first-line drugs was performed: rifampin (RIF), isoniazid (INH), streptomycin (SM), and ethambutol (EMB) using the proportion method, and genotyping was performed using the standard RFLP-IS6110 method. Information was collected from case registries in health facilities, as well as from clinical records. Results: Out of 118 M. tuberculosis isolates, 97 genetic profiles were identified, with between 2 to 15 bands per profile. 29.7% of isolates originated 14 genetic groups or clusters, while the others showed variable patterns in their bands. On te other hand, resistance profiles revealed that nearly 33% of participating subjects who never received any previous therapy had drug resistance, as well as 58% of those previously treated. Multidrug resistance was present in 8.42% and in 36% of those never before treated and those previously treated, respectively. Conclusions: This analysis revealed the existence of epidemiologically- or clonally-related genetic groups with no evidence for multidrug resistant strains transmission.
        Objetivos: Conocer los perfiles genéticos de M. tuberculosis y determinar el patrón de resistencia a drogas en una población de sujetos infectados provenientes del sur de Lima mediante el marcador genético IS6110 (RFLP-IS6110). Materiales y Métodos: Entre octubre de 2002 y abril de 2003 se incluyeron pacientes mayores de 15 años con tuberculosis (TB) pulmonar frotis positivo procedentes de servicios de salud del distrito Villa María del Triunfo y del Hospital María Auxiliadora. Se realizó la prueba de sensibilidad a las cuatro drogas de primera línea rifampicina (RIF), isoniacida (INH), estreptomicina (SM) y etambutol (EMB) por el método de proporciones, y la genotipificación mediante el método estándar de RFLP-IS6110. Se recolectó información de los casos de los registros del establecimiento e historias clínicas. Resultados: De 118 aislamientos de M. tuberculosis se identificaron 97 perfiles genéticos variando entre 2 a 15 bandas por perfil. El 29,7% de los aislamientos dio origen a 14 grupos o clusters genéticos mientras que el resto mostró patrones variables de bandas. De otro lado, los perfiles de resistencia revelaron que cerca de 33% de los sujetos participantes nunca tratados presentaron resistencia a drogas y 58% de los tratados con anterioridad. La multidrogoresistencia fue de 8,42% y 36% en los nunca y anteriormente tratados respectivamente. Conclusiones: Nuestro análisis revela la existencia de grupos genéticos con relación epidemiológica o clonal sin evidencia de transmisión de cepas resistentes a múltiples drogas.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: Spanish
    refInfo:
    copyright:
      @attributes:
        flag: Y
      custom: Copyright of Revista Peruana de Medicina Experimental y Salud Pública is the property of Instituto Nacional de Salud (Peru) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use.
      item: Revista Peruana de Medicina Experimental y Salud Pública
      holder: Instituto Nacional de Salud (Peru)
      dt:
        @attributes:
          year: 2005
    holdings:
      @attributes:
        islocal: N